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Summary
We consider a problem of reducing the expected number of treatment failures in trials where the 
probability of response to treatment is close to 1 and treatments are compared based on log odds 
ratio. We propose a new class of urn designs for randomization of patients in a clinical trial. The 
new urn designs target a number of allocation proportions including the allocation proportion that 
yields the same power as equal allocation but significantly less expected treatment failures. The 
new design is compared with the doubly adaptively biased coin design, the efficient randomized 
adaptive design and with equal allocation. The properties of the new class of designs are studied 
by embedding them into a family of continuous time stochastic processes.
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1. Introduction
Consider the problem of comparing two treatments in a randomized clinical trial. An issue 
that is central to such a trial is balancing the ethical imperative to assign more patients to the 
better treatment with the need to have sufficient power to compare the treatments. Response 
adaptive designs change allocation away from equal allocation based on responses observed 
so far in the trial; see Hu and Ivanova, 2004, and Hu and Rosenberger, 2006, for review. 
Early response adaptive designs, generalized Pólya urn (Athreya and Karlin 1968; Zhang et 
al., 2006), the play-the-winner rule (Zelen, 1969) and the randomized play the winner rule 
(Wei and Durham, 1978) were developed for comparing treatments with binary outcomes to 
yield “ethical” allocation in the limit, that is, to assign more patients to the better treatment. 
Their limiting allocation, as well as the limiting allocation for the urn design of Ivanova 
(2003), though “ethical”, is not optimal with respect to maximizing power of the treatment 
comparison. In some cases, a trial with allocation proportion that is not optimal in terms of 
power, requires many more subjects to achieve the same power than equal allocation. This 
can result in observing more failures in the trial than under equal allocation, therefore 
defeating the purpose of a response adaptive design to reduce the average number of failures 
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(Eisele, 1994; Hu and Zhang, 2004), and the efficient randomized adaptive design (ERADE) 
(Hu, Zhang and He, 2009) can target any desired allocation including the allocation that 
maximizes power.
An important metric of any allocation procedure is the amount of randomness it provides. In 
a deterministic procedure the next assignment can be predicted for sure if all previous 
assignments and outcomes, in case of response adaptive allocation, are known. On the other 
side of a spectrum is a fully randomized allocation procedure, an allocation via a fair coin, in 
case of equal allocation, or biased coin otherwise. We use entropy to measure randomness of 
the designs, a measure that has not been used before when response adaptive designs were 
compared. This allows making a fair comparison of adaptive procedures since deterministic 
procedures are more efficient in targeting the desired allocation.
Hu and Rosenberger (2003) showed that the power of treatment comparison is closely 
related to the variability of the allocation proportion: the higher the variability the lower the 
power. The variability of the allocation proportion depends on the type of allocation 
procedure as well as on the allocation that the design targets and the amount of randomness 
it provides. The urn design of Ivanova (2003) yields the lowest variability as it achieves the 
lower bound of the asymptotic variance of the allocation proportion (Rosenberger and Hu, 
2003; Hu, Rosenberger and Zhang, 2006), so does the ERADE (Hu, Zhang and He, 2009). 
The doubly adaptive coin design achieves the lower bound only when the procedure is 
deterministic (Rosenberger and Hu, 2003). Randomness and the variability of the allocation 
proportion in the ERADE and the doubly adaptive coin design depends on the value of the 
design parameter. When several response adaptive designs that target the same allocation are 
compared, their corresponding design parameters can be set to provide the same amount of 
randomness, then the best design is the one that has the lowest variability of the allocation 
proportion.
Zhang et al. (2011) put the lowest variability urn design of Ivanova (2003) and other urn 
models into a general framework of immigrated urn models. In this paper, we generalize the 
design of Ivanova (2003) in a different way by allowing the change in the urn composition 
to depend on several previous outcomes, not only the most recent outcome. This new 
generalization allows targeting a large spectrum of allocation proportions, including 
allocations that yield good power of treatment comparison. Since the design of Ivanova 
(2003) yields the lowest variability of the allocation proportion the new design has low 
variability as well and the result has better power than competitors. The generalization, 
however, creates challenges in obtaining theoretical properties of the design since the new 
design can no longer be embedded into a family of stochastic processes unless 
multidimensional state space is considered.
Our motivating example is the Comparison of Arixtra in Lower Limb Superficial Vein 
Thrombosis with Placebo (CALISTO) trial (Decousus et al., 2010). This was a randomized 
trial comparing a new drug Arixtra with placebo in patients with acute symptomatic 
thrombophlebitis of the lower limbs. The primary efficacy outcome was a composite of 
death from any cause or symptomatic pulmonary embolism or symptomatic deep-vein 
thrombosis or symptomatic extension to the saphenofemoral junction or symptomatic 
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recurrence of superficial-vein thrombosis at day 47. The observed success probabilities were 
99.1% in Arixtra arm and 94.1% on placebo. Similar success probabilities for placebo are 
often observed in other cardio-vascular trials. For example, 30-day mortality is a commonly 
used primary endpoint in trials comparing therapies for acute myocardial infarction, these 
trials yield around 93%-95% non-failure rate (Hjalmarson et al., 1985; Tebbe et al., 1998). 
The mortality rates are usually compared via log odds ratios. Response adaptive designs are 
beneficial for trials like these because they reduce the number of failures on average and 
increase power of treatment comparison, if the treatment is better than placebo, because 
when highly successful treatments are compared based on log odds ratios or relative risk the 
power is maximized when more patients are assigned to the better treatment (Dette, 2004).
In this paper in Section 2 we review possible target allocations for trials comparing two 
treatments. We introduce higher order urn designs in Section 3. Simulation results are 
described in Section 4. In Section 5 we re-design the CALISTO trial. Section 6 is a 
discussion section.
2. Optimal allocations
Consider the case where two treatments are compared. Let Ni(n) be the number of subjects 
assigned to treatment i, i = 1, 2, by the time a total of n subjects have been assigned, N1(n) + 
N2(n) = n. The allocation proportion to treatment 1 by the time n patients have been assigned 
is N1(n)/n. The optimal allocation proportion can be determined by using multiple-objective 
optimality criteria (see Jennison and Turnbull, 2000, for more details). If treatment outcomes 
are binary from Bernoulli(pi), 0 < pi < 1, qi = 1 − pi, i = 1,2, the allocation proportion on 
treatment 1, , Neyman allocation, minimizes the variance of 
. Alternatively, it minimizes the total sample size required to achieve given power if 
the Wald’s test statistic is used to test H0: p1 − p2 = 0. The allocation that minimizes the 
expected number of failures for a fixed variance of the estimate of the parameter of interest 
or for fixed power (Rosenberger et al., 2001) is . Another allocation 
to mention is ρ3 = p1q1 / (p1q1 + p2q2); it yields the same power as equal allocation (see 
discussion of ρ3 in Baldi Antognini and Giovagnoli, 2010). When the log odds ratio, 
log[p1q2 / q1p2)], is estimated the three corresponding allocations are 
,  and .
Ivanova and Rosenberger (2001) noted that response adaptive designs are most 
advantageous in trials with highly successful treatments, or, equivalently, trials with low 
probability of a bad event occurring for the following two reasons. First, in such trials 
treatment failure is often death (Hjalmarson et al., 1985; Tebbe et al., 1998) or severe 
disability (Connor et al., 1994; Simoons et al., 2002; Wallentin et al., 2003) and therefore it 
is most desirable to minimize the number of treatment failures. Second, if treatments are 
compared based on log odds ratio, the allocation that maximizes power, allocation , 
assigns more patients to the better treatment when both success probabilities are higher than 
0.5. In case of highly successful treatments, the allocation  might be even a better target 
for a response adaptive design than allocation  since it assigns even more patients to the 
better treatment and therefore further reduces the expected number of failures. For example, 
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the optimal allocations for success probabilities p1 = 0.991 and p2 = 0.941 observed in 
CALISTO trial are  = 0.717,  = 0.869 and  = 0.866. The total number of failures 
observed in CALISTO trial was 101, 13 out of 1502 in Arixtra arm and 88 out of 1500 in 
placebo arm. The allocation ratio  = 0.866 would have yielded 46 total failures out of 3002 
patients on average if the true rates were equal to those observed in CALISTO trial, 
reducing the average number of failures by 55. For small sample sizes the limiting allocation 
 might not be reached, still, the trial most likely will result in an allocation somewhere in 
(0.5, ], yielding better power and reduced number of failures compared to equal allocation. 
Therefore  is an ideal target allocation in trials with highly successful treatments.
3. Higher order urn designs for binary outcomes
3.1. The second order urn design for binary outcomes
We introduce the second order urn design to create an urn design that focuses on variability 
of the estimated treatment effect rather than the mean. As the result the new design targets 
allocation proportions that are optimal or nearly optimal in terms of power, such as 
allocation . Also, by modifying a low variability design from Ivanova (2003), we obtain a 
low variability design and therefore we expect the new design to have good power compared 
to competitors as variability affects power negatively (Rosenberger and Hu, 2003). The 
design is defined as follows:
Second order urn design—The urn contains balls of three types. Balls of types 1 and 2 
represent the two treatments. Balls of type 0 are called immigration balls. Initially the urn 
contains 2b + a balls; b (≥0), balls of each treatment type and a (>0), immigration balls. 
Assume that j patients have been treated so far, with at least one patient assigned to each 
treatment. If the jth patient was assigned to treatment i, let  be this patient’s outcome. 
A ball is drawn from the urn at random. If the ball is of type 0, i.e., an immigration ball, no 
subjects are assigned to treatment, and the ball is returned to the urn together with 2 
additional balls, one of each treatment type. If a ball corresponding to treatment i is drawn, i 
= 1, 2, the next subject is assigned to treatment i and an outcome  is observed. If 
, where  is the outcome of the previous subject assigned to 
treatment i, the ball is not returned. Otherwise, the ball is returned to the urn.
In the urn design of Ivanova (2003) the ball is not returned to the urn if there is a failure on 
the corresponding treatment. In the second order urn design the ball is not returned to the urn 
if the two most recent responses on the treatment are different. This increases the allocation 
to the treatment with smaller variance, thus changing the urn composition according to the 
variability rather than the actual outcome.
3.2. Limiting allocation proportion and variability of the second order urn design
When a response adaptive design is investigated, of most interest is the limiting distribution 
of the proportion of patients assigned to each treatment. To obtain this distribution for the 
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second order urn design, we use the technique of embedding the design into a family of 
continuous time stochastic processes (Athreya and Ney, 1972; Ivanova et al., 2003). Let Zm 
= (Zm0, Zm1, Zm2) denote the urn composition after m consecutive draws, including draws of 
immigration balls, where Zm0 is the number of immigration balls and Zmi is the number of 
balls of treatment type i, i = 1,2. Define the continuous time analog of the urn as follows. Let 
τm be the time of the mth draw, and τ = 0. Given the urn composition after m draws, Z(τm) = 
(Zm0, Zm1, Zm2), generate three independent random variables V0, V1, and V2, such that Vi 
has exponential distribution with mean 1 / Zmi, i = 0,1, 2. Let Tm+1 = min(V0, V1, V2) and 
define τm+1 = τm + Tm+1. If Tm+1 = Vi the drawn ball is of type i. The urn composition after 
m + 1 draws, Z(τm+1), is obtained as described in Section 3.1. The stochastic processes {Zm; 
m = 0,1,2,…} and {Z(τm); m = 0,1,2,…} have the same transition probabilities and therefore 
are equivalent. It can be shown that τm → ∞ almost surely (Athreya and Ney, 1972). We 
define Z(t), t > 0, to be the right continuous version of Z(τm), Z(t) = (Z0(t), Z1(t), Z2(t)). This 
defines Zi(t), i = 0,1,2, as the number of balls of type i at time t. See Athreya and Ney 
(1972), Ivanova et al. (2000), Ivanova (2003) and Ivanova (2006) for more details on 
embedding a discrete type stochastic process into a continuous type process. As a result, the 
urn design can be described by using the notion of continuous time which is a useful 
mathematical construct not related to the real time in the medical experiment. Let Ui(t) be 
the number of draws of a ball of treatment type i resulting in a success on treatment i, and 
Yi(t) be the number of draws of a ball of type i resulting in a failure on treatment i, so that 
the number of trials on the ith treatment is Ni(t) = Ui(t) + Yi(t), i = 1,2. Let I(t), the 
immigration process, be the number of draws of balls of type 0, immigration balls. By 
construction Zi(t) = Zi(0) + I(t) − Yi(t). The total number of draws of a ball of treatment type 
i, Ni(t) is of most interest to us, while the number of balls in the urn, Zi(t), is the quantity that 
defines the process. The stochastic processes literature focuses on Zi(t). Ivanova et al. (2000) 
extended the technique from Cox and Miller (1965, p. 265) to obtain the differential 
equation for the joint probability generating functions. To describe the behavior of Ni(t), we 
will obtain its joint probability generating function with the number of balls in the urn, Zi(t), 
G(i)(,t z w) = E (zzi(t)wNi(t)). Since the two most recent responses are used, consider the 
generating function  describing the behavior of the process corresponding to 
treatment i when the preceding state was 0, the penultimate outcome on treatment i was a 
failure, and  describing the behavior of the process when the preceding state is 
1, the penultimate response on treatment i was a success. Then we have
Using backward equations, the following system of equations is obtained (see Appendix I 
for more details):
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Initial and boundary conditions are  and G(i)(t, 1, 1) = 1, i = 
1, 2, with t ≥ 0, |z| ≤ 1, and |w| ≤ 1.
The quantity Ni(t) / [N1(t) + N2(t)] is the allocation proportion to treatment i by time t. By 
construction, it is also the allocation proportion to treatment i among the first J(t) patients in 
the embedded urn process, where J(t) = N1(t) + N2(t). As t → ∞ therefore, if both J(t) → ∞ 
and Ni(t) / [N1(t) + N2(t)] converges in probability to a limit, then this limit is equal to the 
limiting allocation proportion in the urn process. We now sketch a demonstration that this is 
indeed so. For more details, see Ivanova et al. (2000); Ivanova (2003).
The limit of the allocation proportion can be computed (Ivanova, 2003) by first obtaining
It might not be possible to obtain the closed form solution of the system of equations (1) 
except for special cases. Using characteristic function approach (Ivanova et al., 2000) we 
can show that limt→∞ E{Ni(t) / t} is a / (2piqi), where the limit is in probability, and that 
Ni(t) → ∞, i=1,2, almost surely as t → ∞. Hence J(t) → ∞ almost surely, as required. 
Next, similarly to Ivanova (2003), the limit in probability of the allocation proportion is
which is  defined in Section 2. This demonstrates that the limiting allocation in the 
embedded urn process is .
The variability can be assessed by computing
where G(1,2)(t, 1, w1, w2) is a joint function for N1(t) and N2(t) (see Ivanova, 2006, for 
details). It was not possible to obtain the closed form expressions for var {N1(t)}, varN2(t) 
and cov{N1(t), N2(t)} for given t and as t→∞, so we resorted to numerical computations.
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3.3. Higher order urn designs
In Section 3.1 we introduced the design that is an extension of the low variability design 
from Ivanova (2003) and uses two most recent responses instead of one response as in the 
original Ivanova design. In this section we extend the design further by using three or more 
responses. This extension creates designs that target an even wider range of allocation 
proportions and converge faster than the second order urn design while keeping variability 
low as before.
To describe this extension we first note that the second order design defined in Section 3.1 
can be alternatively defined using the estimate of success probability obtained from the two 
most recent observations. The estimate , i =1, 2, can take on three 
possible values 0, 1/2 and 1. The ball of type i is not returned if  = 0.5. Similarly, in the kth 
order urn design, the estimate of success rate is based on the k most recent responses: 
. Let an integer α be such that k = 2α, if k is even, or k = 2α + 1, if 
k is odd. Consider the kth order design where the ball is not returned if  or 
, that is, the ball is not returned if the estimate of success rate is the closest 
possible to 0.5. The probability of not returning the ball is  if k = 2α, or 
 if k = 2α + 1. Here 
 is a binomial coefficient with , if α < 0 or α > k. The limiting 
allocation proportion for this urn design (Ivanova, 2003) is equal to 
. For example, when k = 3 (so that α = 1) the 
limiting allocation proportion is ρ(α = 1) = p2q2 / (p1q1 + p2q2) = , when k = 4, the 
allocation is . For p1 > p2 and α > β, ρ(α) > ρ(β), therefore for 
all α > 1 ρ(α) is closer to 1 than ρ(1) = . Allocations ρ(α) for α > 1 might be desirable for 
trials with the goal of selecting the best treatment, however, as was discussed in Section 2, 
the power under allocations ρ(α) with α > 1 is lower than under  or under equal allocation.
With the use of a biased coin the kth order urn design can be made to target the desirable 
allocation . The kth order urn design with biased coin, k = 4, 5…, that targets  is 
described as follows. If m successes were observed in the last k patients assigned to 
treatment i, i =1, 2, the ball of type i is not returned if 1) the estimated success probability 
from the last k patients assigned to treatment i is away from 0 or 1, that is, m = 1,…, k−1; 
and 2) a biased coin with probability of heads equal to  lands heads. 
To show that this design targets , we first compute the probability of not returning the ball
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Therefore the limiting allocation is equal to Q2/(Q1 + Q2) = p2q2/(p1q1 + p2q2) = . For 
example, when k = 4, the possible values for  are 0, 1/4, 1/2, 3/4, and 1. According to the 
design described above, the ball is not returned if  = 1/2; or if  = 1/4,3/4 and a biased 
coin with the probability of heads equal to 3/4 lands heads. When k = 5, the ball is not 
returned if  = 2/5, 3/5; or if  = 1/5, 4/5 and a biased coin with the probability of heads 
equal to 2/3 lands heads.
4. Comparison with competing designs
In this section we compare the new urn designs with the doubly adaptive biased coin design 
(Hu and Zhang, 2004) and the efficient randomized adaptive design (Hu, Zhang and He, 
2009).
The doubly adaptive biased coin design (Hu and Zhang 2004) allocates patient j to treatment 
i with probability , where  is the target proportion estimated from the 
data. We use the choice of g from Hu and Zhang (2004):
Here γ is a design parameter controlling the amount of randomization in the design. Let 
ρ(p1, p2) be the target allocation proportion as a function of p1 and p2, for example, 
 for inverse Neyman allocation. Hu and Zhang (2004) 
give the following formula for the asymptotic variance, ω2, of N1(n)/n
When γ = 0, the design is fully randomized, and the variance is ; when γ = +∞ the 
design is deterministic, the variance is  and is equal to the lower bound of the asymptotic 
variance. Hu and Rosenberger (2005) recommended using the design with γ = 2.
The ERADE (Hu, Zhang and He, 2009) is a generalization of Efron’s coin which attains the 
lower bound of the asymptotic variance and can target any desirable allocation. The ERADE 
requires specifying a design parameter π, 0 ≤ π < 1, that reflects the degree of 
randomization, with larger values of π corresponding to more randomization and variability. 
The design is defined as follows. As before,  is the estimated target allocation for treatment 
1. Then the next patient is assigned to treatment 1 with probability  if the actual allocation 
to treatment 1 exceeds ; with probability  if the actual allocation is equal to the estimated 
target allocation; with probability 1−(1− )π if the actual allocation is below the estimated 
target allocation. Hu, Zhang and He (2009) studied the choice of π and found that the 
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simulated results of π = 1/8 and 1/4 were very similar to the results of π = 1/2 in terms of 
allocation proportion and its variability, and the ERADE with π = 3/4 has a slightly larger 
variability than others. They recommended using π in [0.4, 0.7]. Since the ERADE with π = 
0.5 performed very similar to lower values of ERADE we used the ERADE with π = 0.5.
We compared designs based on variability of allocation proportion and randomness. 
Randomness was quantified by summing entropy of the allocation distribution for each 
assignment, , where ξj is the probability of being assigned to treatment 1 
after (j − 1) patients have been assigned. For a given p1 and p2, the sample size, N, used for 
entropy calculations was that which yields 80% power with a two-sided type I error rate of 
0.05 for testing based on the log odds ratio. For the adaptively biased coin design 
. In the case of the third order urn design, ξj is equal to 
, where zi(j) is the number of balls of 
type j in the urn right after the most recent treatment (non-immigration) ball was chosen, and 
the sum is over the number of immigration balls m to be drawn before a treatment ball is 
drawn. The product in the denominator is the probability that m − 1 immigration balls are 
chosen before z(j) is finally chosen. We have not been able to obtain a closed form for the 
sum. Noting that the sum of all terms after the mth term is less than the mth term (see 
Appendix II) it is easy to obtain the numerical value for the sum with any degree of 
accuracy. We computed the sum within 10−14 of the true value.
First, we compare the asymptotic variance of the second and third order urn designs with the 
lower bound of the asymptotic variance of designs that target  and the asymptotic variance 
of the doubly adaptive biased coin design with γ = 2. Fig. 1 displays the asymptotic 
variances for p2 = 0.90 and p1 in [0.90, 0.99]. Even though the design from Ivanova (2003) 
achieves the lower bound of the asymptotic variance, the higher order urn designs do not, 
but their variances are very close to the lower bound and are significantly smaller than those 
of the biased coin design with γ = 2.
Second, for each (p1, p2), we computed the sample size required to achieve 80% power in a 
trial with equal allocation. Then we compared response adaptive designs using these sample 
sizes. We compared the second and third order urn designs to the adaptively biased coin 
design with γ = 2 and ERADE with π = 0.5 for values of p1 and p2 greater than 0.5 based on 
the variance of the allocation proportion and on the amount of randomness the designs 
provide. The regions of (p1, p2) sample space where the third order urn design has higher 
entropy, which is more desirable, are marked with vertical lines in Fig. 2. Elements of 
(p1,p2) space where the asymptotic variance for the third order urn design was smaller are 
marked with horizontal lines in Fig. 2. In Section 2 we proposed  as the target allocation in 
a trial where treatment comparison is based on the log odds ratio. The first row of Fig. 2 
shows the comparison with the adaptively biased coin design and the ERADE targeting , 
the second row targeting . Fig. 2 shows that the third order urn design performs well 
against the adaptively biased coin design and the ERADE targeting  in about half of the 2-
dimensional region of (p1, p2). When the coin design and the ERADE target  the region 
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where the new design is better is smaller, however, the advantage of the proposed design 
still holds for trials where highly successful treatments are compared.
5. Example: re-designing CALISTO trial
The proposed approach is illustrated by re-designing the CALISTO trial (Decousus et al., 
2010). The total sample size in the trial was 3002 patients with 1502 patients assigned to 
Arixtra and 1500 to placebo. The sample size of 3000 was chosen because it yields the 
power of 87% to detect a 2 percentage point absolute increase in incidence of events at the 
two-sided 0.05 level of significance using Fisher’s exact test, provided the incidence in the 
placebo group is no greater than 2%. Observed success probabilities were p1 = 0.991 in the 
Arixtra arm and p2 = 0.941 in placebo arm. For p1 = 0.991 and p2 = 0.941, the optimal 
allocations are  = 0.717, which minimizes the sample size given power,  = 0.869, which 
minimizes the expected number of failures given power, and  = 0.866, the allocation that 
yields the same power as equal allocation but less treatment failures. The limiting allocation 
for our proposed urn design coincides with . For the success probabilities in the CALISTO 
trial both the coin design and the ERADE perform better when targeting , therefore we 
describe simulation results for these two designs for  target only. To redesign the 
CALISTO trial we first found the values of parameters γ in the coin design and π in the 
ERADE design that yield the same randomness, measured by the total entropy, as the third 
order urn design. These parameters were γ = 0 for the coin design and π = 0.28 for the 
ERADE. Then trials with assignments by the coin design and the ERADE were simulated. 
Results are presented based on 5000 simulated trials. The simulation study was repeated 
with recommended values γ = 2 and π = 0.5 yielding similar conclusions. To simulate the 
CALISTO trial we resampled from CALISTO data knowing that 13 out of 1502 failures 
were observed in Arixtra arm and 88 out of 1500 in placebo arm. Results when data were 
simulated from Bernoulli distribution with success probabilities p1 = 0.991 and p2 = 0.941 
were very similar. If equal allocation is used and true probabilities are p1 = 0.991 and p2 = 
0.941, 536 subjects total are required to achieve 90% power in a two-sided test with the type 
I error rate of 0.05. As the sample size in the CALISTO trial was much larger than needed 
we re-designed the trial as a two-stage trial with the Pocock boundary (Pocock, 1977) to 
allow stopping early for efficacy after outcomes from the first 1500 patients were observed. 
In fact, all trials were stopped for efficacy after 1500 patients essentially yielding a single 
stage trial with a total sample size of 1500. The average number of failures and the 5th and 
95th percentiles were 33 (25, 42) for the coin design, 34 (28, 41) for ERADE, 30 (26, 34) for 
the urn design and 50 (43, 59) for equal allocation. All response adaptive designs 
dramatically reduced the total expected failures with the new urn design yielding the 
smallest number of failures.
Fig. 3 shows power curves in the informative region of total sample sizes, between 300 and 
600, for the third order urn design, the ERADE, and equal allocation. Power for the 
adaptively biased coin design is inferior and is not shown. As seen from Fig. 3, the proposed 
urn design has better power than equal allocation and the ERADE. Better power for the urn 
design is the result of low variability of the allocation proportion (Fig. 4). The average 
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allocation proportion and its 25th and 75th percentiles (Fig. 4) show that the allocation 
proportion of the doubly adaptive coin design and the ERADE converges to the limiting 
proportion quickly, but that the variability of the allocation proportion is high. For example, 
for the total sample size of 300, the allocation proportion in 10% of the trials is 90:10 or 
more extreme when the target is, in fact,  = 0.717. This makes the design more sensitive to 
time trends and to have low power in case multiple interim analyses are performed. Though 
the urn design converges more slowly, it is far less variable.
We also performed simulations with delayed response. As shown by Bai, Hu and 
Rosenberger (2002) the asymptotic properties of response adaptive designs under delay in 
outcome are the same as without a delay unless the delay is substantial and as long as 
adaptations are done frequently. We assumed that the data from the first patient were only 
available when the kth patient was enrolled, the data from the second patient were available 
when the (k+1) patient was enrolled etc. For example, if k ≥ 1500 in a trial with 1500 
patients total, no data are available to modify the allocation proportion. If no data were 
available to modify the allocation proportion patients were randomized by flipping a fair 
coin. A delay with k = 500 yielded 39, 39 and 38 failures on average for the coin design, the 
ERADE and the urn design with fewer failures observed on average than 50 failures under 
equal allocation. Significant delay of k = 1000 in a trial of 1500 yielded 44, 44 and 45 
failures on average for the three adaptive designs, only slightly fewer failures than under 
equal allocation with faster converging coin and ERADE designs now performing better 
than the urn design. Note that if the adaptations of the allocation proportion are only 
performed once or twice during the trial, the proposed urn design is not suitable and the 
adaptively biased coin or the ERADE should be used. Both the coin design and the ERADE 
estimate the success probabilities using all available data and compute the desirable 
allocation proportion.
6. Conclusions
The doubly adaptively biased coin design and ERADE estimate success probabilities from 
all available data, then estimate the target allocation which is a function of these 
probabilities and therefore can target any allocation proportion that is a function of success 
probabilities. Both designs converge rapidly to the target, however, the variability of the 
allocation proportion is high as well. The proposed higher order urn design does not estimate 
success probabilities from all data but rather takes them into account indirectly using only 
the most recent data. It, therefore, converges to the target allocation more slowly, however, 
is far less variable. In the example considered, the third order urn design does not result in 
extreme allocations and yields higher power than the doubly adaptive coin design, the 
ERADE and equal allocation. Another advantage of the proposed urn designs is that one 
does not have to know the most recent estimates of the treatments’ success probabilities p1 
and p2. For the third order urn design, for example, one only needs to know if there were any 
failures among the most recent 3 responses. Therefore, if data used for a recent adaptation 
accidently become known to investigators, they will not know the most recent estimates of 
p1 and p2.
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In the CALISTO trial example where two highly successful treatments were compared, all 
three response adaptive designs yielded substantial savings in failures compared to equal 
allocation. The proposed third order urn design and the ERADE resulted in similar or better 
power than equal allocation. Therefore, it is worth considering response adaptive designs as 
a design option for trials with highly successful treatments.
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APPENDIX I
Though we have two processes corresponding to the two treatment arms, it is sufficient to 
describe the behavior of a Markov process corresponding to a single treatment arm with 
success rate of p, q = 1 − p. In similar derivations in Ivanova et al. (2001) and Ivanova 
(2003) the state that the process is in was a function of the number of balls currently in the 
urn. In the second order urn, the state that the process is in is determined by the response of 
the previous patient and the number of balls currently in the urn. The initial urn contains one 
ball of each type. Assume that one patient has been already treated and response observed. If 
the response was a success, X1 = 1, the Markov process starts at the state (1,1), if response 
was a failure, X1 = 0, the Markov process starts at the state (0,1). Assume that the process is 
at the state (0, m), m > 0, at time t. The following transitions are possible in time Δt:
Similarly, if the process is in the state (1, m), m > 0, at time t, the transitions in time Δt are:
Let p0,m(t) equal the probability of being at state (0, m) at time t, and p1,m(t) equal the 
probability of being at state (1, m) at time t. To obtain backward equations we consider all 
possible ways to get to states (0,m) and (1,m) by time t:
(2)
Define generating functions
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The system of partial differential equations (1) and its initial and boundary conditions are 
obtained from (2) and (3).
APPENDIX II
Define , m ≥ 0. We would like to 
show that . We first show that, aj,m+1 / aj,m ≤ 0.5. This ratio is
because all terms are nonnegative and z1(j) + m ≥ 1.
The geometric sequence 0.5n has the property that the sum of all terms beyond the mth term 
is equal to the mth term. Then, aj,m+k < (aj,m)(0.5)k and therefore .
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The asymptotic variance of the second order urn design (dashed line), the third order urn 
design (dotted line) and the doubly adaptive biased coin design with parameters γ = 2 (upper 
solid line) and γ = ∞ (lower solid line). Success rate p2 = 0.9.
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Range of success probabilities p1 and p2 where third order urn design has smaller asymptotic 
variance (horizontal lines) and higher entropy (vertical lines) than the doubly adaptive coin 
design with γ = 2 (left panel) or ERADE with π = 0.5 (right panel). The diagonal line is the 
boundary of the sample space. The first row is for the coin design and ERADE targeting , 
the second for .
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Power for the CALISTO trial with p1 = 0.991 and p2 = 0.941 for third order urn design 
(solid line), the equal allocation (dotted-dashed line) and the ERADE with π = 0.28 targeting 
 (dotted line).
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Allocation proportion and its 25th and 75th percentiles for the trial with p1 = 0.991 and p2 = 
0.941 for third order urn design (solid lines), the doubly adaptive coin design with γ = 2 
(dashed lines), and ERADE with π = 0.5 (dotted lines) plotted against the sample size.
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